Alcon (ALC) Equity Income (2009 - 2019)

Alcon's (ALC) quarterly Equity Income came in at $49.0 million in Q2 2019, up 800.0% quarter-over-quarter from -$7.0 million in Q3 2009.

Alcon (ALC) Equity Income (2009 - 2019) Analysis & Trends

Alcon's Equity Income history runs 2 years deep, the most recent figure standing at $49.0 million for Q2 2019.

On a quarterly basis, Equity Income changed N/A year-over-year to $49.0 million in Q2 2019; TTM through Jun 2019 was $49.0 million, a N/A change from a year earlier, with the FY2025 full-year figure at -$18.0 million, down 125.0% from the prior year.
Equity Income grew to $49.0 million in Q2 2019 per ALC's latest filing, from -$7.0 million in the prior quarter.
Across five years, Equity Income topped out at $49.0 million in Q2 2019 and bottomed at $49.0 million in Q2 2019.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Equity Income (Qtr)
1	Alcon	33,163,703.85 Bn	33,163,702.19 Bn	1.53 Bn	-
2	Intuitive Surgical	119.67 Bn	114.45 Bn	1.96 Bn	-
3	Becton Dickinson	43.92 Bn	43.11 Bn	2.15 Bn	-
4	Medline	31.71 Bn	29.47 Bn	1.84 Bn	-
5	Resmed	28.46 Bn	26.80 Bn	890.98 Mn	-
6	West Pharmaceutical Services	23.80 Bn	23.28 Bn	296.40 Mn	-
7	Cooper Companies	13.77 Bn	13.63 Bn	735.40 Mn	-
8	Solventum	13.63 Bn	13.06 Bn	1.10 Bn	-
9	Align Technology	11.94 Bn	10.88 Bn	736.59 Mn	-
10	Baxter International	11.56 Bn	9.54 Bn	891.00 Mn	-

Download Data